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Abstract
The power prior has been widely used in many applications covering a large number of 
disciplines. The power prior is intended to be an informative prior constructed from historical 
data. It has been used in clinical trials, genetics, health care, psychology, environmental health, 
engineering, economics, and business. It has also been applied for a wide variety of models and 
settings, both in the experimental design and analysis contexts. In this review article, we give an A 
to Z exposition of the power prior and its applications to date. We review its theoretical properties, 
variations in its formulation, statistical contexts for which it has been used, applications, and its 
advantages over other informative priors. We review models for which it has been used, including 
generalized linear models, survival models, and random effects models. Statistical areas where the 
power prior has been used include model selection, experimental design, hierarchical modeling, 
and conjugate priors. Prequentist properties of power priors in posterior inference are established 
and a simulation study is conducted to further examine the empirical performance of the posterior 
estimates with power priors. Real data analyses are given illustrating the power prior as well as the 
use of the power prior in the Bayesian design of clinical trials.
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1. Introduction
Informative prior elicitation is one of the biggest and most important topics in Bayesian 
inference. Bayesian inference using informative priors is becoming more widely used in an 
age of massive datasets and prior information including settings such as clinical trials and 
observational studies. Informative prior elicitation is typically not an easy task since it is 
typically not easy to quantify and synthesize prior information into a suitable prior. Thus, 
techniques and methods for synthesizing and quantifying prior information are highly 
needed. In the presence of historical data, informative prior elicitation can proceed in a 
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much more systematic fashion, and in such cases, the quantification of prior information is 
more straightforward, and even “objective” in some sense.
The power prior discussed in [1] has emerged as a useful class of informative priors for a 
variety of situations in which historical data are available. The first paper to discuss the 
formalization of the power prior as a general prior for various classes of regression models is 
[1]. Several applications to clinical trial design and analysis as well as epidemiological 
studies using historical data in prior elicitation have appeared in the literature. Examples of 
papers discussing the use of historical data in prior elicitation include [2, 3, 4, 5, 6, 7]. 
Papers using the power prior and its variations include [8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 
18, 19, 20, 21, 22, 23, 24]. Books illustrating the use of the power prior in epidemiological 
studies and clinical trials contexts include [25, 26].
One of the reasons that the power prior has become such a powerful tool in the last decade 
as an informative prior in both design and analysis settings is because of its ease in 
construction and its natural form for incorporation of historical data, its attractiveness in 
interpretation, its relative ease in computation, its attractive theoretical properties and uses in 
model selection problems, and because of the relatively few hyperparameters that need to be 
specified. It is an ideal tool as an informative prior in settings where historical data are 
available and is arguably the most widely used informative prior in such settings. The power 
prior is a useful general class of priors that can be used for arbitrary classes of regression 
models, including generalized linear models, generalized linear mixed models, survival 
models with censored data, frailty models, multivariate models, and nonlinear models. The 
power prior specification for the regression coefficients focuses on observable quantities in 
that the elicitation is based on historical data D0 and a scalar parameter a0 quantifying the 
heterogeneity between the current data D and the historical data D0. The power prior 
distribution is then constructed by raising the likelihood function of the historical data to the 
power a0, where 0 ≤ a0 ≤ 1. Such constructions of prior distributions have been discussed by 
[27, 1]. The power prior provides, in some sense, an “objective” and historical data-driven 
approach to informative prior elicitation. It is objective in the sense that the degree of 
informative-ness of the prior is driven by the information contained in the (“objective”) 
historical data, not from expert opinion elicited on parameters in the model. The only 
hyperparameter that requires subjective elicitation in the power prior is the discounting 
parameter a0, for which we highly recommend several sensitivity analyses, including 
analyses with a0 = 0 (non-informative prior) and a0 = 1 (full borrowing).
A formal justification of the power prior is given in [15] where it is shown to be an optimal 
class of informative priors in the sense that it minimizes a convex sum of Kullback-Leibler 
(KL) divergences between two specific posterior densities, in which one density is based on 
no incorporation of historical data, and the other density is based on pooling the historical 
and current data. This result provides a strong motivation for using the power prior as an 
informative prior in Bayesian inference. In addition, a formal relationship between this 
convex sum of KL divergences and the information processing rules proposed by [27, 28] is 
derived. Specifically, Ibrahim, Chen, and Sinha [15] showed that the power prior is the 
100% efficient information processing rule in the sense defined by [27]. The power prior 
also has close connections with hierarchical modeling as shown in [16]. Chen and Ibrahim 
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[16] showed that the parameter a0 has a direct analytic connection with the variance 
hyperparameter in the prior for the mean function in a normal hierarchical model.
The rest of the paper is organized as follows. In Section 2, we introduce the basic 
formulation of the power power and review various variations of the power prior, including 
the full power prior, the normalized power prior, the commensurate power prior, the partial 
discounting power prior, and the partial borrowing power prior. The issue of fixed or 
random power parameters, extensions to multiple historical datasets, and the power prior for 
generalized linear models are all reviewed and presented in Section 2. An in-depth review of 
the theory of the power prior and its properties, including the theoretical justification, 
connections to hierarchical models, the power prior as a conjugate prior, the property of 
matching predictives, and the power priors in variable selection, is given in Section 3. 
Section 4 includes entirely new development. In Section 4, we examine frequentist 
properties of the posterior estimates using power priors in linear models as well as 
generalized linear models. In Section 5, the determination of a guide value of the power 
parameter is reviewed and new derivations for the linear model are obtained for estimating 
the guide value along with a new simulation study to examine the empirical performance of 
the power prior. Section 6 reviews seven applications of the power prior in various research 
fields. The use of the power prior for survival analysis in the context of cancer clinical trials 
as well as in the Bayesian design of non-inferiority clinical trials is demonstrated in Sections 
7 and 8 with new analyses. We conclude the paper with a brief discussion in Section 9.
2. The Power Prior
2.1. Basic Formulation of the Power Prior
The power prior can be constructed as follows. Let the data for the current study be denoted 
by D and denote the corresponding likelihood function by L(θ|D), where θ is a vector of 
parameters. Suppose we have historical data D0 from a similar previous study. Let L(θ|D0) 
denote the likelihood function for the historical data D0. Here, L(θ|D) and L(θ|D0) are 
general likelihood functions for arbitrary models, such as normal linear models, generalized 
linear models, random effects models, nonlinear models, or survival models with censored 
data.
The basic formulation of the power prior, as discussed in [1], is
(2.1)
where 0 ≤ a0 ≤ 1 is a scalar parameter and π0(θ) is the initial prior for θ before the historical 
data D0 is observed. In many applications, π0(θ) is taken to be an improper prior. Using the 
power prior in (2.1), the corresponding posterior distribution of θ is given by
(2.2)
We see from (2.2) that a0 weights the historical data relative to the likelihood of the current 
study, and thus the parameter a0 controls the influence of the historical data on L(θ|D). The 
parameter a0 can be interpreted as a precision parameter for the historical data. Since D0 is 
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historical data, it is unnatural in many applications such as clinical trials to weight the 
historical data more than the current data; thus it is scientifically more sound to restrict the 
range of a0 to be between 0 and 1, and thus we take 0 ≤ a0 ≤ 1. One of the main roles of a0 
is that it controls the heaviness of the tails of the prior for θ. As a0 becomes smaller, the tails 
of (2.1) becomes heavier. Setting a0 = 1, (2.1) corresponds to the update of π0(θ) using 
Bayes theorem. That is, with a0 = 1, (2.1) corresponds to the posterior distribution of θ 
based on the historical data. When a0 = 0, then the prior does not depend on the historical 
data D0; in this case, π(θ|D0, a0 = 0) ≡ π0(θ). Thus, a0 = 0 is equivalent to a prior 
specification with no incorporation of historical data. Therefore, (2.1) can be viewed as a 
generalization of the usual Bayesian update of π0(θ). The parameter a0 allows the 
investigator to control the influence of the historical data on the current study. Such control 
is important in cases where there is heterogeneity between the previous and current studies, 
or when the sample sizes of the two studies are quite different. One of the most useful 
applications of the power prior is for model selection problems since it inherently automates 
the informative prior specification for all possible models in the model space (see [1, 12, 
13]). The power prior given by (2.1) will be proper if the initial prior π0(θ) is proper. The 
propriety issue of the power prior arises when an improper initial prior, such as π0(θ) ∝ 1, is 
specified. If , the initial prior plays a dominant role in the power prior 
since in this case, the historical data may not contain much information about the parameters 
θ. However, even in this case, we are still able to evaluate the extent of information 
contained in the power prior about θ by taking a proper initial prior. The role of the initial 
prior in the power prior for model selection was extensively discussed and carefully 
examined in [12].
Since the power prior is basically a likelihood function raised to a power, it shares all of the 
properties that likelihood functions have, and therefore has several advantages over other 
priors. Some of these advantages include
(i) Propriety: techniques for showing propriety of π(θ|D0, a0) are exactly the same 
as those for showing propriety for a posterior distribution based on a dataset D0 
with likelihood function L(π|D0), and prior π0(θ).
(ii) A semi-automatic prior elicitation scheme for variable subset selection and 
general model selection problems.
(iii) Asymptotics: Since the power prior is a likelihood raised to a power, all of the 
asymptotic results for likelihood theory carry over to the power prior.
Propriety results for the power prior are not difficult to characterize since one can use results 
from likelihood theory to obtain necessary and sufficient conditions for obtaining propriety 
of the power prior for a wide class of models. Ibrahim, Ryan, and Chen [10] and Chen, 
Ibrahim, and Yiannoutsos [12] developed such results for the power prior based on logistic 
regression, Chen, Ibrahim, and Shao [14] established general results for GLMs, Chen et al. 
[11, 29] examined propriety results for the cure rate model and piecewise exponential 
model. For the asymptotic property, it can be shown that for many classes of models that as 
, where  is the mode of the power prior and 
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. This was demonstrated in many applications and models 
by Ibrahim and his co-workers.
2.2. Variations of the Power Prior
In many applications of the power prior, one may take a0 to be fied and then do several 
sensitivity analysis using different values of a0. However, one can also develop the 
hierarchical prior specifiation by taking a0 random and specifying a beta distribution for it, 
for example. In this case, the full prior specification becomes
(2.3)
where π0(θ) and π0(a0) are the initial priors. We call (2.3) the joint power prior.
Another modification of the power prior when a0 is random, which was introduced by [19, 
30], is called the normalized power prior, and is given by
(2.4)
where π0(θ) and π0(a0) are the initial prior.
The main difference between (2.3) and (2.4) is that (2.3) specifies a joint prior distribution 
directly for (θ, a0) while (2.4) first specifies a conditional prior distribution for θ given a0 
and then specifies a marginal distribution for a0. For the normalized power prior in (2.4), we 
must have  for 0 < a0 ≤ 1. The joint power prior in (2.3) may or 
may not need to be proper as long as the resulting posterior is proper. However, when 
, the joint power prior in (2.3) is proper and can be rewritten as
(2.5)
In this case, the joint power prior can also be viewed as a normalized power prior with the 
normalizing constant free of a0. An in-depth examination of the propriety of the joint power 
prior in (2.3) can be found in [14] for GLMs and in [31] for generalized linear mixed 
Models (GLMMs).
An extension of the power prior introduced by [22] allows for different parameters for the 
historical and current data. Hobbs et al. [22] called such a prior the commensurate power 
prior. To illustrate this idea, we consider θ and θ0 as the one-dimensional parameters for the 
current and historical data, respectively. A vague initial prior is chosen for θ0 and the prior 
for θ depends on θ0 and τ, where τ parameterizes commensurability between θ and θ0. The 
information on τ is used to guide the prior on a0. Assuming a uniform improper initial prior 
for θ0, the commensurate power prior is given by
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where , which is the commensurate prior, 
 is a function of the commensurability parameter that is small 
for τ close to zero and large for large values of τ, and π0(τ) is an initial prior of the 
commensurate parameter. The variations of the commensurate power prior have been 
recently developed and discussed in [23, 26].
The other formulation of the power prior, which is now called the “partial discounting 
power prior”, is especially useful and most easily motivated in latent variable models, where 
one wishes to discount the likelihood function of the historical data but not discount the 
distribution of the latent variables. The partial discounting power prior is formulated as
(2.7)
where ξ is a vector of latent variables in the model, and g(ξ) is the distribution of the latent 
variables. We see in this formulation that the discounting occurs only in the likelihood 
function of θ based on the historical data, conditional on the latent variables, and the latent 
variable distribution g(ξ) is not discounted. Chen, Dey, and Shao [32] used (2.7) in the 
context of skewed link models for dichotomous response data, where g(ξ) denotes a skewed 
distribution of latent variables ξ. The partial discounting power prior is attractive in the 
sense that information in the historical data is typically available on the regression 
parameters but not directly on the distribution of the latent variables in the model. In 
addition, (2.7) is more computationally advantageous than the full discounting power prior, 
which is defined as . The partial discounting 
power prior is not restricted to latent variable models. This idea can easily be extended to 
models with random effects in which g(ξ) may depend on an additional unknown variance 
parameter τ of random effects (e.g., [24]). The variations of the partial discounting power 
priors have also been developed in the literature, including [32, 33, 34, 35, 36].
In addition, a more recent variation of the power prior is called the partial borrowing power 
prior formally-introduced by [24]. The idea of the partial borrowing power prior can be 
traced back to [8] in analyzing human twin data, in which only summary statistics from the 
historical studies were available and consequently, the prior information was available only 
for certain parameters. Shao [37] also discussed the partial borrowing power prior method in 
toxicity study design and benchmark dose estimation. Chen et al. [21] used the partial 
borrowing power prior to borrow the historical data only for the control device from 
previous medical device trials. The key idea of the partial borrowing power prior is that the 
historical data are borrowed only through the common parameters shared in the models for 
the historical data and the current data. Thus, strength from the historical data is borrowed 
through those common parameters and at the same time, the parameters in the power prior 
are allowed to be different than those in the likelihood function for the current data. This 
attractive and flexible feature of the partial borrowing power prior allows the historical data 
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to have different forms (e.g., summary statistics versus individual-level data) or different 
models than the current data. Moreover, the partial borrowing power prior can be adapted to 
the fixed-a0, random a0, normalized, and commensurate settings. Chen et al. [21], Ibrahim et 
al. [24], and Chen et al. [38, 39] applied the partial borrowing power prior for clinical trial 
design.
2.3. Fixed or Random a0
When a0 is fixed, we know exactly how much historical data D0 are incorporated into the 
analysis of the current data D, and also how the type I error and power are related to a0 in 
Bayesian design of clinical trials, which is discussed in detail in Section 8. In addition, there 
is a theoretical connection between the power prior formulation and the hierarchical prior 
specification, as established in [16]. Some useful comments on the fixed a0 case can be 
found in [18]. When a0 is random, we need to compute the prior normalizing constant, given 
by
(2.8)
This normalizing constant is often analytically intractable except for normal linear 
regression models.
2.4 Computations of the Power Prior
The computational properties of the power prior were discussed in many papers, including 
[9, 10, 11, 12, 13, 14, 29]. The power prior for variable subset selection was demonstrated in 
[12, 13, 31, 33, 40].
When a0 is fixed, the implementation of Markov Chain Monte Carlo (MCMC) sampling 
from the posterior distribution becomes straightforward, especially for complex models such 
as generalized linear models, random effects models, nonlinear models, or survival models 
with censored data. The joint power prior formulation is more computationally intensive 
than the a0 fixed case. The normalized power prior formulation is even more 
computationally extensive than the joint power prior formulation for models other than 
normal linear regression models since for most non-normal models, an analytical evaluation 
of the integral,  in (2.4), is not available, which poses a huge challenge 
in sampling from the resulting posterior distribution and computing the posterior quantities 
of interest. To circumvent the computational issues that arise from the normalized power 
prior, one may extend the Monte Carlo method developed in [41] to compute the posterior 
quantities and the computational algorithms developed in [42, 43, 44] to sample from the 
posterior distribution.
2.5. Extension to Multiple Historical Datasets
Multiple historical datasets often arise in clinical trials, observational studies, 
carcinogenicity studies, and environmental studies. For example, in phase II and phase III 
clinical trials, a particular treatment is tested several times under various conditions within a 
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certain population. Suppose we have K0 historical datasets, D0k, k = 1,..., K0. Write D0 = 
(D01, ··· , D0K0). By extending (2.1) to the K0 historical datasets, we have
(2.9)
where π0(θ) is the initial prior for θ, a0 = (a01, ··· , a0K0), and 0 ≤ a0k ≤ 1 for k = 1,..., K0. 
The prior in (2.9) is attractive since it allows for diffierent a0k's for diffrent historical 
datasets, providing a flexible degree of discounting for each historical dataset. The 
theoretical and computational properties of (2.9) are similar to those of the single historical 
dataset case, and (2.9) can also be extended to the variations of the normalized power prior 
discussed in Section 2.2. The power prior for multiple historical datasets has been discussed 
in the literature and used in several applications, including [1, 15, 16, 19, 21, 31, 30, 45, 46, 
47].
2.6. The Power Prior for Generalized Linear Models
Let yi he the response variable and also let xi be a p-dimensional vector of covariates for i = 
1,... ,n for the current study. Write D = {(yi, xi), i = 1,...,n} = (n, y, X), where y = (y1,..., yn)′ 
and . Throughout the paper, we assume a generalized linear model 
(GLM) for yi given xi, which has a density in the exponential class 
, indexed by the 
canonical parameter θi and the scale parameter τ. The functions ψ and ϕ determine a 
particular family in the class, such as the binomial, normal, Poisson, etc.. The function αi(τ) 
is commonly of the form  where the wi's are known weights. Further 
suppose the θis satisfy the equations: θi = h(ηi) and , where h is a monotone 
differentiable function, often referred to as the link function and  is a p-
dimensional vector of regression coefficients.
We assume that τ is known and denote αi ≡ αi(τ) and ϕ(yi) ≡ ϕ(yi, τ)throughout the 
remainder of the paper. For the binomial and Poisson regression models, τ is intrinsically 
equal to 1. We further rewrite  under the GLM as 
, i = 1,..., n. In the special case 
of the normal linear regression model, we have
(2.10)
The likelihood function of the current data D is given by 
Similarly, let  denote the historical data, 
where  and . We assume the GLM for y0i, 
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given by , i = 1,..., n0, 
where  and x0i is a p-dimensional vector of covariates in the historical data. In 
the special case of normal linear regression, we have
(2.11)
The likelihood function of the historical data D0 is given by 
and the power prior in (2.1) with a fixed a0 for the GLM is given by 
, where 0 ≤ a0 ≤ 1 and π0(β) is the initial prior of β. In 
the normal linear regression case, the power prior reduces to 
. Assume that we take an 
improper uniform initial prior for β, i.e., π0(β) ∝ 1. Then we have
(2.12)
Similarly, the normalized power prior (2.4) with a random a0 for the GLM takes the form 
, where π0(a0) is the initial prior for a0,
(2.13)
and π0(β) is the initial prior for β. We may simply consider π0(a0) ∝ 1, i.e., a0 ~ beta(1,1). 
We note that a closed form expression of (2.13) under the GLM is not available except for 
the linear model, in which we have 
.
3. Theory of the Power Prior and its Properties
3.1. Theoretical Justification of the Power Prior
The power prior in (2.1) has attractive theoretical properties. First, the power prior is an 
optimal class of informative priors in the sense that it minimizes a convex sum of Kullback-
Leibler (KL) divergences between two posterior densities  (no 
borrowing) and  (full borrowing), where  is given 
in (2.2). Mathematically, Ibrahim, Chen, and Sinha [15] showed that 
, where 
 and 
. Second, the power prior 
in (2.1) is a 100% efficient processing rule in the sense that  minimizes the 
Ibrahim et al. Page 9













weighted information-processing rule (Zellner [28], [48]) defined by Δ[g] = output 
information – weighted input information = , where , 
0 ≤ a0 ≤ 1, and . Similar results have been 
established in [30] for the normalized power prior in (2.4) based on Shannon's mutual 
information theory. Extensions of these results to multiple historical datasets can be found in 
[15, 30].
3.2. Connections to Hierarchical Models
Hierarchical modeling is a common method for combining several datasets or incorporating 
prior information. Chen and Ibrahim [16] established a formal connection between the 
power prior and hierarchical models for the class of generalized linear models via an 
approximate relationship between the power parameter a0 and the variance components of 
the hierarchical model. This connection facilitates a direct interpretation and estimation of a0 
and unifies these two different approaches for incorporating prior information.
For the GLMs, the power prior is given in Section 2.6. Under the hierarchical GLM 
specification, We take  for the current data and 
for the historical data. In order to establish the connection between the power prior and the 
hierarchical model for GLMs, we further assume that Ω is fixed and specify an improper 
uniform initial prior for μ, i.e., π0(μ) ∝ 1. Under the hierarchical formulation, the posterior 
distribution of β give D and D0 is given by , 
where  is the joint posterior distribution of β, β0 and μ. Chen and Ibrahim 




,  and 
 are the maximum likelihood estimates (MLEs),  and  are the Hessian matrices of 
 and  evaluated at the respective MLEs of β, and L(β|D) and L(π|D0) 
are the likelihood functions under the GLMs. Similarly, under the power prior formulation, 
the posterior distribution  corresponding to the power prior 
given in (2.12) with  can be approximated by
(3.2)
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where  and . We note that (3.1) and (3.2) are the 
exact posterior distributions in the special case of normal linear regression. Chen and 
Ibrahim [16] showed that the approximate posterior distributions in (3.1) and (3.2) match, 
i.e.,  and  if and only if , where Ip is the p × p identity 
matrix. Chen and Ibrahim [16] proposed a guide value for a0 based on this analytical 
connection and discussed extensions to multiple historical datasets as well as the case in 
which Ω is unknown.
3.3. The Power Prior as a Conjugate Prior
For GLMs, it turns out that a special case of the power prior is a conjugate prior. That is, if 
we take D0 = (n, y0, X), where y0 is a prior elicitation of the response vector for the current 
data D = (n,y,X) (y0 is not historical data here), then the power prior reduces to a conjugate 
prior. Prior elicitation of observable quantities has been examined in detail by [50, 51, 52, 
53]. If , the conjugate prior is given by
(3.3)
where a0 > 0 is a scalar prior parameter, and y0 = (y01,..., y0n)′ is an n × 1 vector of 
hyperparameters. In (3.3), (y0, a0) have different meanings and interpretations than that of 
the historical data case of the earlier subsections. Now y0 is a prior prediction for y, and a0 
reflects the degree of confidence in that prediction. Thus, a0 is no longer restricted to be 
between 0 and 1 in this conjugate prior situation, and we only need a0 ≥ 0. We denote the 
conjugate prior by . As shown in [53], the resulting posterior 
distribution takes of the form .
We now briefly discuss the elicitation of y0 for the conjugate prior. There are two ways of 
eliciting y0. First, in the case of direct elicitation, one can use expert opinion or case-specific 
information on each subject. We can also elicit y0 from forecasts or predictions obtained 
from a theoretical prediction model. In this case, we could obtain a point prediction y0 based 
on a previous similar study. Second, in the case of indirect elicitation, we can specify y0 
indirectly through a prior specification for the prior mode μ0 of β. As shown in [53], 
 yields a prior mode of β equal to μ0, where 
. In the context of binary regression, , where 
F is a cdf. When μ = 0 and F is the cdf corresponding to a symmetric distribution, then y0 = 
(1/2,..., 1/2)′. Many other interesting special cases for the specification of y0 as well as the 
elicitation of a0 for GLMs can be found in [53].
3.4. Matching Predictives
Another attractive feature of the power prior examined in [54] is that it has the property of 
matching predictives. In variable selection or model selection problems, many authors have 
advocated the notion that the priors for the parameters should somehow “match” across the 
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models in the model space. For example, for two nested models, the prior specification for 
the parameters “in common” between these two models should be consistent in some sense.
Suppose we have two nested models  and take the priors  i = 1, 2, where 
the prior predictive densities  and  are given by 
 for i = 1,2. For variable subset selection in linear 
models, it turns out that the power prior is the class of priors that minimizes the discrepancy 
between  and , when the discrepancy measure is the symmetric KL 
divergence, defined by
(3.4)
To illustrate this, we first consider the linear model with no covariates, i.e., the intercept 
model, y = μ + ε, where . Take the prior for μ as 
. Then the prior predictive distribution of y is given by
(3.5)
Now consider the linear model with covariates given by y = Xβ + ε, where 
. We take the prior for β as . Then we have
(3.6)
As shown in [54], as a function of (β0, Σ0), DSKL in (3.4) is minimized when 
 and . That is, the power prior is the prior that 
minimizes the discrepancy between the prior predictive distribution with no covariates (i.e., 
(3.5)) and the prior predictive distribution with covariates (i.e., (3.6)).
3.5. Variable Selection Problems
The power prior is “semi-automatic” in the sense that once one identifies the likelihood 
function of the historical data, then the kernel of the power prior is immediately determined 
with minimal prior elicitation. One only has to elicit a single scalar a0. This type of prior 
elicitation scheme is very powerful in variable selection problems, since by the mere 
specification of likelihood function of the historical data, the hyperparameters of the power 
prior for all possible subset models in the model space are automatically determined. A 
detailed discussion of this semi-automated elicitation scheme based on the power prior for 
variable selection in linear models can be found in [51] and [55]. Chen, Ibrahim, and 
Yiannoutsis [12] developed the power prior for variable selection and computation in the 
GLM, Chen et al. [31] extended these results to generalized linear mixed models, Ibrahim 
and Chen [1] and Ibrahim, Chen, and MacEachern [13] developed the variable selection 
methodology and computation for power priors in the Cox regression model, and Ibrahim, 
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Chen, and Ryan [40] developed the power prior for variable selection and its computational 
properties for time series models.
For the GLM, Chen, Ibrahim, and Yiannoutsos [12] used the power prior to specify both a 
prior for the regression coefficients for all subset models in the model space and prior 
probabilities for all models in the model space. To do this, they let p denote the number of 
the regression coeffiients including an intercept for the full model and let  denote the 
model space. They enumerate the models in  by k = 1,..., , where  is the dimension 
of  and model  denotes the full model. Also, they let  denote 
the regression coefficients for the full model including an intercept, and let  denote a pk 
× 1 vector of regression coefficients for model k with an intercept, and a specific choice of 
pk – 1 covariates. They take  as the historical data for model k, where 
 is an n0 × pk design matrix. Under model k, Chen, Ibrahim, and Yiannoutsos [12] 
proposed the following form of the power prior based on  for :
(3.7)
where  is the initial prior for , c0 is a fixed hyperparameter, and a0 is the 
discounting parameter. The parameter c0 controls the impact of  on the entire 
prior, and the p arameter a0 controls the influence of the historical data on . 
From (3.7), we see how the prior distribution of  is automatically determined from the 
historical data for all models in the model space. All one needs to do is just to specify the 
historical data  and elicit the discounting parameter a0 and the 
hyperparameter c0.
To specify prior probabilities for all models on the model space  using the historical data 
D0. Chen, Ibrahim, and Yiannoutsos [12] first specified the prior for  as
(3.8)
where  is the same density as that in (3.7) with c0 replaced by d0, and then 
defined the prior probability for mode k as
(3.9)
In (3.8), the parameter d0 is a scalar prior parameter that controls the impact of 
on the prior model probability π(k|D0,d0) in (3.9). The prior model probability π(k|D0,d0) 
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defined by (3.8) and (3.9) has several nice properties. First, π(k|D0,d0) in (3.9) corresponds 
to the posterior probability of model k based on the historical data D0 using a uniform initial 
prior  for . Second, as d0 → 0, then π(k|D0,d0) reduces to a uniform prior 
on the model space. Therefore, as d0 → 0, the historical data D0 have minimal impact in 
determining π(k|D0,d0). On the other hand, with a large value of d0,  plays a 
minimal role in determining π(k|D0, d0), and in this case, the historical data plays a larger 
role in determining π(k|D0, d0). Thus as d0 → ∞, π(k|D0, d0) will be regulated by the 
historical data. The parameter d0 plays the same role as c0 and thus serves as a tuning 
parameter to control the impact of D0 on the prior model probability π(k|D0, d0).
For the GLM, the prior  and the prior model probability π(k|D0, d0) given 
in (3.7) and (3.9) lead to convenient and efficient computation of the prior and posterior 
model probabilities. The computational algorithms developed in [12] only require two Gibbs 
samples, one from the prior and another from the posterior under the full model, to compute 
the prior and posterior model probabilities for all possible models in .
4. The Role of Power Priors in Posterior Inference
In Subsections 4.1 and 4.2, we consider new developments. In particular, we wish to 
theoretically examine the behavior of the posterior variance of β and the marginal variance 
of the posterior mean of β as the discounting parameter a0 is varied between 0 and 1. 
Studying these properties is important since it shows how the marginal variance is reduced 
or maximized as a function of the discounting parameter a0. We show that for the linear 
model and generalized linear model that the marginal variance of the posterior mean of β is 
always less than or equal to the posterior variance of β and that equality is only attained 
when a0 = 0 and a0 = 1 and the maximum discrepancy between the two variances is attained 
at a0 = 0.5.
4.1. The Normal Case
Assume that we take an improper uniform initial prior for β, i.e., . Suppose that 
L(β|D) and L(β|D0) are the likelihood functions in (2.10) and (2.11). Then, the posterior 
distribution of β is given by
(4.1)
for 0 ≤ a0 ≤ 1. From (4.1), we see that the posterior mean and variance of β are given by 
 and
(4.2)
Theorem 4.1 Let Var( ) denote the varianee of  with respect to the marginal distribution 
of (y, y0) defined by (2.10) and (2.11). Assume that X and X0 are of full rank. Then, we have
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for 0 ≤ a0 ≤ 1, where  is the posterior variance of β and “≤” denotes that 
 is a positive semi-definite definite matrix. In addition, the 
equality in (4.3) holds if and only if a0 = 0 or a0 = 1 and the maximum difference between 
Var(β|D, D0, a0) and  is reached at a0 = 0.5.
The proof of Theorem 4.1 is given in Appendix A.
REMARK In view of the frequentist properties of the posterior estimates of β, the results 
established in Theorem 4.1 imply that for 1 ≤ j ≤ p, (i) the 100(1 – α)% HPD interval of βj 
has exact coverage probability of 1 – α when a0 = 0 or a0 = 1; (ii) the coverage probability 
of the 100(1 – α)% HPD interval of βj is greater than 1 – α when 0 < a0 < 1; (iii) the highest 
coverage probability of the 100(1 – α)% HPD interval of βj is attained at a0 = 0.5.
4.2. The General Case
Using the GLMs, the posterior distribution of β is given by 
. Following [49, 16] and ignoring constants 
that are free of the parameters, we have  and 
 where L(β|D) and L(β|D0) are the likelihood 
functions,
 and  are the respective MLEs of β based on D and D0 under the GLMs, and  and 
 are the Hessian matrices of log L(β|D) and logL(β|D0) evaluated at the respective MLEs 
of β. Then, it is straightforward to show that under the GLMs,  and 
, where  and  are n × n diagonal matrices with ith diagonal elements 
 and  evaluated at , where hi = 
h(ηi) and , and  and  are n0 × n0 diagonal matrices with ith diagonal elements 
 and  evaluated at , 
where  and . The above approximations are valid for large n and large 
n0, respectively. Assuming , we obtain 
, where 
. Again, using the 
asymptotic variances of  and , it can be shown that the sample variance of the posterior 
mean  is given by 
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and the posterior variance of β is approximated by 
. Here,  is taken with respect 
to the marginal distribution of (y, y0). Thus, we are led to the following corollary.
Corollary 4.1 Theorem 4.1 holds approximately for the GLMs when n and n0 are large and 
X and X0 are of full rank.
5. The Choice of a0
One of the most important issues in the use of the power prior is what value of a0 to use in 
the analysis. There are several possible solutions to this issue. The easiest solution is to 
establish a hierarchical power prior by specifying a proper prior distribution for a0, such as a 
beta prior, for example. A uniform prior on a0, might be a good choice or a more 
informative prior would be to take a0 ~ beta(c, c), where c is moderate to large, such as c ≥ 
3. Although a prior for a0 is attractive, it is more computationally intensive than the a0 fixed 
case and all closed forms are lost when taking this approach. The a0 random case has been 
discussed in [1, 10, 12, 13, 15, 19, 22, 23, 30, 45, 46, 47, ?, 56, 57, ?].
Another approach is to take a0 as fixed and elicit a specific value for it and conduct several 
sensitivity analyses about this value, or to take a0 fixed and use a model selection criterion. 
To facilitate the choice of a0, for the normal linear model, we derive here expressions for the 
penalized likelihood-type criterion, marginal likelihood criterion, deviance information 
criterion, and logarithm of the pseudo-marginal likelihood criterion for the linear model as 
well as present a new simulation study in Section 5.6. As discussed in [15], the guide values 
based on the criteria discussed below serve only as a starting point for the analysis, and 
several sensitivity analyses should be carried out in the range of the guide values.
5.1. The Penalized Likelihood-type Criterion
Ibrahim, Chen, and Sinha [15] proposed a penalized likelihood-type criterion (PLC) to 
determine a guide value of a0. This criterion takes of the form 
, where
(5.1)
L(β|D) and L(β|D0) are the likelihood functions under the GLMs, and π0(β) is the initial 
prior. Then, the guide value of a0 based on the PLC is given by
(5.2)
For the normal linear model, when , (5.1) reduces to 
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and the PLC in takes the form 
.
5.2. The Marginal Likelihood Criterion
We take the power prior distribution of β given D0 and a0 in (2.13) with an initial prior 
. Then, the marginal likelihood is defined as
(5.3)
The guide value of a0 according to the marginal likelihood criterion is given by
(5.4)
Note that when a0 > 0 and X0 is of full rank,  in (2.13) is still proper. For the 
normal linear model, when  and a0 > 0, we have 
.
5.3. The Deviance Information Criterion
For the GLMs, the deviance function is defined as 
. 
The Deviance Information Criterion (DIC) (Spiegelhalter et al. [58]) is given by
(5.5)
where  and . Using (5.5), 
the optimal value of a0 according to DIC is given by
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Now, we present a closed form expression of DIC for the normal linear model whose 
detailed derivation is given in Appendix A. In this special case, the deviance function 
reduces to 
. 
The DIC for the normal linear model is given by
(5.7)
It is interesting to see that when a0 = 0, we have pD(a0 = 0) = tr(X′X[X′X]−1)= p, which is 
exactly the same as the dimension of β. In addition, pD(a0) decreases when a0 increases.
A Special Case: When p = 1, X = (1,1,..., 1)′, and X0 = (1,1,..., 1)′, which corresponds to an 
intercept model, we have  and 
, where  It is easy to show that 
. Therefore, we obtain  if  and 
 if . This result is quite interesting since if 
 then  decreases when n0 increases.
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5.4. The Logarithm of the Pseudo-Marginal Likelihood Criterion
Let  denote D with the ith observation deleted. Then, for the ith observation, the 
Conditional Predictive Ordinate (CPO) is defined as 
, where 
 denotes the posterior density of β given , and a0. Following 
Geisser [59] and Gelfand, Dey, and Chang [60], we have 
, where 
 is the posterior distribution under the GLM. Then, the logarithm of the 
Pseudo-marginal likelihood (LPML) in [61] is defined as
(5.8)
Using (5.8), the optimal value of a0 according to LPML is given by
(5.9)
For the normal linear model, the CPO reduces to 
. After some 
algdbra, we obtain the LPML for the normal linear mo el as 
 Note that when 
a0 = 0, using a first-order Taylor's series expansion, we have 
. For a detailed derivation of the LPML 
for the normal linear model, see Appendix A.
5.5. Multiple Historical Datasets Case
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Thus, the guide value of a0 based on PLC in (5.11) is given by
(5.12)
where 0 (1) is a K0-dimensional vector with all elements equal to 0 (1). Similarly, we can 
extend (5.4), (5.6), and (5.9) to obtain the guide values of a0 for multiple historical datasets. 
For brevity, the details are omitted here.
5.6. A Simulation Study
We carry out a simulation study to examine the empirical performance of the power prior 
with fixed a0 and random a0 for the normal linear regression model. The model for the 
current data is  and  for i = 1,..., n, where the εi's are 
independent, and the model for the historical data is  and 
for i = 1,..., n0, where the εi0's are independent. We further assume that the εi's and the εi0's 
are independent. In all simulated datasets, we assume that the xi's and xi0 are independently 
generated from a N(0,1) distribution. We consider two scenarios: (i) the historical and 
current data are similar and (ii) the historical and current data are different. In Scenario I, we 
set β0 = β00 = 1, β1 = β10 = 2 n = 400, and n0 = 200; and in Scenario II, we set β0 = β00 = 1, 
β1 = 2, β10 = 1.75, n = 400, and n0 = 200. We also consider two additional scenarios: 
Scenario III, we set β0 = β00 = 1, β1 = β10 = 2 n = 200, and n0 = 400; and Scenario IV, we set 
β0 = β00 = 1, β1 = 2, β10 = 1.75 n = 400, and n0 = 200. The simulation results are given in 
Appendix B.
We generated 10,000 simulated datasets under each scenario. For each simulated dataset, we 
computed the posterior means, the posterior standard deviations, and the 95% HPD intervals 
of β1 using the power prior (2.1) with 21 fixed a0 values ranging from 0 to 1 with an 
increment of 0.05, and four estimated optimal a0 values, namely, , and 
 given by (5.2), (5.4), (5.6), and (5.9), respectively, as well as using the normalized 
power prior (2.4). In all cases, an improper initial prior, , was specified, and a 
uniform prior on (0,1) was taken for a0 for the normalized power prior. Based on the 10,000 
simulated datasets, we then calculated the average of the posterior means (Estimate), the 
average of the posterior standard deviations (SD), the coverage probability (CP) of the 95% 
HPD intervals, and the root of the mean square error (rMSE) for β1.
The simulation results are shown in Table 1. The coverage probabilities and rMSE's are also 
plotted in Figure 1. From Table 1 and Figure 1, we see that under Scenario I, the highest CP 
is 0.9606, which is achieved at a0 = 0.5. This empirical result is consistent with the 
theoretical result established in Theorem 4.1. The posterior estimates based on  were 
very similar to those under a0 = 0.10 under both scenarios. The guide values 
and  led to similar posterior estimates under both scenarios. Compared to the SD's 
and rMSE's for fixed a0 values, we see that , and the random a0 were 
equivalent to approximately borrowing 50% of the historical data under Scenario I and about 
30%-40% of the historical data under Scenario II. In Scenario II, the random a0 power had 
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the largest rMSE; the power prior with  had the smallest rMSE; and the power prior 
with guide values , and , as well as a random a0 was over-borrowing the 
historical data, resulting in CPs around 90%, which were lower than 95% as expected. In 
general, the guide value  leads to less borrowing while the other three guide values 
and a random a0 yield more borrowing.
6. Applications of the Power Prior
The power prior has been recently applied in many fields such as clinical trials, 
epidemiological studies, environmental health, genetics, health services research, etc.. In this 
section, we provide a snapshot overview on the use and implications of the power prior in 
various biomedical applications. The non-medical applications of the power prior are given 
in Appendix C.
6.1. Heritability Estimates in Human Genetics Research
In human genetics research, twin studies are often used as an initial process for testing a 
specific trait that is genetically influenced. One of the goals of these studies is to estimate 
the heritability in twin data. The heritability, denoted by h2, is defined as twice the 
difference of the intraclass correlation coefficients of monozygous (MZ) and dizygous (DZ) 
twins. The twin data consist of n1 MZ pairs of response variables,  for j = 
1,..., n1; and n2 DZ pairs of response variables,  for j = 1,..., n2. The 
assumed model is , where  and Xij is a matrix of 
covariates for i = 1, 2. The heritability of the trait is simply h2 = 2(ρ1 – ρ2). The published 
literature on heritability studies typically report sample sizes and intraclass correlations of 
MZ and DZ only. Therefore, the data from the kth historical study can be written as 
, where r01k and r02k are intraclass correlations of MZ and DZ, 
for k = 1,...,K0. Write D0 = (D01,..., D0K0).
Often twin studies require great effort and much expense. Thus, the data are comprised of a 
small number of subjects. In typical analyses of human twin data in the literature, the 
standard errors of the estimates of the intraclass correlations are based on large sample 
theory, which may not be appropriate for small samples. To overcome these issues, Chen, 
Manatunga, and Williams [8] developed a new Bayesian scheme for analyzing human twin 
data. Specifically, they considered three types of prior distributions based on the complete 
data from previous studies (fully informative prior), summary statistics from the historical 
studies (semi-informative prior), and no historical information (non-informative prior), 
respectively. Their proposed semi-informative power prior based on D0 takes the form
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where  and , k = 1,..., K0 are the Fisher's z transformations of ρi and r0ik, 
respectively for i = 1, 2,  and  are pre-determined 
hyperparameters. From (6.1), we see that (i) the historica data are borrowed only through the 
ρi and (ii) no historical data are available for β and σ2. In this sense, (6.1) can be viewed as a 
partially borrowing power prior. Using a simulation study, Chen, Manatunga, and Williams 
[8] empirically showed that the semi-informative prior is as informative as the fully 
informative prior if the purpose of the study is to estimate the intraclass correlations or 
heritability h2 in twin studies.
6.2. Evaluating Water Quality in Environmental Science
In environmental statistics, one important issue is the evaluation of air or water quality 
standards. One objective of such studies is to estimate the water quality standards in water 
quality data. The data consist of n measurements of water quality (response variable), y = 
(y1,..., yn), and the assumed model is  for i = 1,..., n. The historical data D0 = 
(n0, y0) were collected in previous years and published by the US Environmental Protection 
Agency (USEPA).
One problem in evaluating water quality is that the current data are available over a short 
time period and consequently the sample size is inadequate to provide necessary precision in 
parameter estimation. To overcome this problem, Duan, Ye, and Smith [19] developed a 
novel Bayesian approach in analyzing water quality data. Specifically, they considered the 
power prior approach to incorporate historical data. Their proposed normalized power prior 
based on D0 takes the form
(6.2)
where , k is a pre-specified constant, and δ0 and λ0 are known 
hyperparameters of the prior distribution of a0. As shown in [19], the power prior approach 
in (6.2) improves the precision of the estimatesof the measurements of water quality over 
other approaches.
6.3. Application to Pediatric Quality of Care
In the pediatric quality of care clinics, investigators conducting new research often have 
access to data from previous studies. Therefore, it is scientifically reasonable and 
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advantageous to incorporate the information from previous studies in conducting a new 
study on pediatric quality of care.
In the context of pediatric quality of care, Neelon and O'Mally [57] compared common 
specifications of the power prior and explored whether it is preferable to use fixed a0 or 
random a0, which was also discussed in Section 2.3. They empirically showed that the 
normalized power prior provides a measure of congruence between the current and historical 
data, so that the historical data were downweighted more substantially as the studies 
diverged. They suggested that in real world problems involving large datasets and models 
with several parameters, the normalized power prior may lead to considerably more 
downweighting than desired. Thus, they further recommended that it is perhaps more 
appropriate to assign a0 a fixed value based on expert opinion about the relevance of the 
historical data for the current analysis. Neelon and O'Mally [57] then applied the power prior 
methods to a pair of studies designed to improve delivery of care in pediatric clinics.
6.4. Analysis of Randomized Therapeutic Trials
In randomized therapeutic trials (RTTs), historical data provide a valuable source of 
information for the motivation and design of later trials. One objective of these studies is to 
estimate the intervention effect. In the presence of previous studies, meta-analysis is a well-
known approach for estimating the overall treatment effect. When one is interested in the 
effect of the study-specific subpopulation, however, the historical data based on meta-
analysis would receive too much weight. As a solution to this problem, Charlotte et al. [46] 
established a new Bayesian method for analyzing data from randomized therapeutic trials. 
They evaluated the use of the power prior distribution, illustrated with data from a large 
randomized clinical trial on the effect of ST-wave analysis in intrapartum fetal monitoring.
Charlotte et al. [46] advocated the use of a power prior distribution with pre-specified fixed 
study weights based on differences in study characteristics. They further proposed obtaining 
a ranking of the historical studies via expert elicitation, based on relevance for the current 
study, and then specified study weights accordingly.
6.5. Benchmark Dose Estimation in Toxicology
The benchmark approach is a useful tool in toxicology. One of the aims of these studies is to 
estimate the benchmark dose in the toxicological experiment. The benchmark dose, denoted 
by BMD, is defined as the dose of an environmental toxicant that corresponds to a 
prescribed change in response compared to the background response level. The toxicological 
data consist of n binomial responses y = (y1,...,yn) of an adverse event at a specific dose 
level. The assumed model is , where ni is the number of animals tested at dose 
level xi and pi is the probability that the animals give an adverse response. That is, 
 for i = 1,..., n. The historical D0 = (n0, y0, X0) are available from a recent 
report by the USEPA.
The typical BMD analysis employed by the U.S. EPA ignores the possibility that other 
models might partially reflect the true dose-response relationship. An alternative approach is 
to estimate a Bayesian model averaged (BMA) BMD. Shao [62] compared three methods 
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for integrating historical data from a previous study, including a pooled data analysis, a 
hierarchical model, and the power prior approach, in risk assessment for BMA BMD 
estimation. He empirically showed that the power prior had little influence on current 
estimates when the historical and current data were incompatible.
In the context of the toxicology studies, Shao [37] discussed another power prior approach, 
which borrows “partially” from the common parameter shared in the models for the 
historical data and the current data. Using this power prior, which is called the partial 
borrowing power prior in this paper, Shao [37] empirically showed that the partially 
borrowing power prior successfully achieved the reduction of the uncertainty in the 
estimates of both the parameters of interest and the benchmark dose.
6.6. Hospital Anxiety and Depression Scale in Psychology
In psychometrics, item response theory (IRT) models have been commonly used to express 
the probability of an item response as a function of the item psychometric properties and the 
individual latent characteristics (generally-called abilities). In order to accurately estimate 
the item parameters and the individual abilities, a large number of respondents and many 
items in a test are needed. However, in practice, the administration of a test with a large 
number of items on a large number of subjects may not always be possible. Therefore, the 
use of collateral or historical information in model estimation assumes a particular 
importance. In Bayesian estimation of IRT models, non-informative priors may lead to 
unstable estimates and poor convergence of the Gibbs sampling algorithm. To overcome 
these problems, Matteucci and Veldkamp [56] introduced the power prior in Bayesian 
estimation of IRT models.
Using the data from the Hospital Anxiety and Depression Scale, Matteuchi and Veldkamp 
[56] demonstrated the efficiency of the power prior approach in terms of measurement 
precision with small samples. In addition, Matteuchi and Veldkamp [56] empirically showed 
that the power prior improves not only the precision of the ability estimates but also 
convergence of the Gibbs sampling algorithm.
6.7. Application to Non-inferiority Trials for Anti-infective Products
In the context of the design and analysis of non-inferiority (NI) trials for anti-infective 
products, Gamalo, Tiwari, and LaVange [47] developed a new methodological approach to 
determine NI margins that can utilize all relevant historical data through a novel power 
adjusted Bayesian meta-analysis. They also provided a Bayesian decision rule for the NI 
analysis that is based on a broader use of available prior information and a sample-size 
determination that is based on this Bayesian decision rule. They used the power prior as a 
means to discount historical data and then proposed a new prior, called the order restricted 
power prior, for combining historical data from different types of studies such as 
randomized double-blind studies, randomized open-label studies, observational studies, 
animal models of disease, and Pharmacokinetic-Pharmacodynamic (PK-PD) profiles.
Ibrahim et al. Page 24













For illustrative purposes, we consider that the historical data are from two types of studies. 
Let  denote the random variables corresponding to estimates of the 
treatment response from k historical studies that are not randomized control trials (RCTs) 
and also let  denote the random variables corresponding to 
estimates of the treatment response from m – k historical studies that are RCTs. Write the 
combined historical data as . Assume that 
 for i = 1,..., k and  for i = k + 1,..., m, where μ is 
the population treatment response, αi, i = 1,..., m, are random effects corresponding to the 
study effets, and  i = 1, ..., m, are within-study variabilities. Let  and 
. The order restricted power prior proposed by [47] is given by
(6.3)
where π0(θ) is the initial prior for θ. The joint order restricted power prior therefore takes the 
form , where  is 
the initial prior for (a01, a02). The order constraints on the power parameters in (6.3) serve as 
a means to downweight the influence of the historical data, which are not RCTs. Gamalo, 
Tiwari, and LaVange [47] specified a Dirichlet distribution as the initial prior for the 
transformed variables (u, v, 1 – u – v), where u = a01 and v = a02 – a01, a Dirichlet process 
prior for (α1,..., αm)′, and an improper uniform initial prior for μ.
Gamalo, Tiwari, and LaVange [47] illustrated their proposed method through three case 
studies, including determination of the effect of antibacterial drugs in reducing all-cause 
mortality in hospital-acquired or ventilator-associated bacterial pneumonia (HABP/VABP) 
patients, estimation of the NI margin for trials in HABP/VABP drug development, and 
sample size determination for the treatment of HABP/VABP. They empirically showed that 
the approach of incorporating prior information in the sample size calculations for NI trials 
can result in significant reductions in sample size.
7. A Case Study in Cancer Clinical Trials
Chen et al. [11, 29] and Ibrahim et al. [15, 63] demonstrated the use of the power prior in 
survival analysis settings in the context of melanoma cancer clinical trials. Interferon (IFN) 
was used in two previous Eastern Cooperative Oncology Group (ECOG) phase III 
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melanoma clinical trials, E1684 and E1690. The first trial, E1684, was a two arm clinical 
trial comparing high-dose interferon (IFN) to Observation (OBS) (Kirkwood et al. [64]). 
There were a total of n0 = 286 patients enrolled in the study. The treatment effect favoring 
IFN that was seen in E1684 with respect to both relapse-free survival (RFS) and overall 
survival (OS) was larger than expected and was accompanied by substantial side effects due 
to the high-dose regimen. As a result, ECOG began a second trial (E1690) in 1991 to 
attempt to confirm the results of E1684 and to study the benefit of IFN given at a lower 
dose. The ECOG trial E1690 was a three arm phase III clinical trial, and had treatment arms 
of high dose interferon, low dose interferon, and observation (Kirkwood et al. [65]). This 
study had n = 427 patients on the high dose interferon arm and observation arm combined. 
The two datasets were quite similar with respect to the distributions of several prognostic 
factors, including Breslow depth, number of nodes, performance status, site of primary, and 
stage of disease. Prognostic factor analyses were conducted to examine the significance of 
time trend covariates and institutional effects for each study alone, as well as for the 
combined studies, and these factors were highly non-significant.
Chen, Harrington, and Ibrahim [29] and Ibrahim, Chen, and Chu [63] considered an analysis 
of the E1690 data, using E1684 as the historical data, which was incorporated via the power 
prior. They presented a power prior using the treatment covariate alone based on a piecewise 
exponential model, parametric cure rate model, and semiparametric cure rate model. Here, 
we present an analysis based on RFS and four covariates, which are treatment, age, gender, 
and the interaction of treatment and gender. In our analysis, we used n0 = 285 with deletion 
of one observation due to missing age and gender. We use the cure rate model of [11] to 
carry out the Bayesian analysis for these data. The cure rate model has been a key 
component in the design of adjuvant melanoma ECOG trials, and this model was used to 
design E1690, E1694, and the E1697 adjuvant melanoma trials.
For the ith patient, i = 1,...,n, let yi denote the observed RFS time or censoring time and let vi 
be the censoring indicator variable taking a value of 1 if yi is an RFS time and 0 if it is a 
censoring time. Also, let trti denote the treatment indictor such that trti = 1 if the ith patient 
received IFN and trti = 0 if the ith patient received OBS. As the gender indicator, genderi is 1 
if the ith patient is male and 0 if the ith patient is female. The likelihood function for the 
E1690 data (denoted by D with n = 427) is given by 
, where 
, and 
 is the cumulative distribution function and  is the corresponding density 
function. We further assume a piecewise exponential model for , which is given by 
, where 
, and . Let D0 denote the 
historical E1684 data and the corresponding likelihood function  is defined in a 
similar way as the one for the current data. Then, the power prior in (2.1) reduces to 
, where  is the initial prior, 
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and  is the likelihood function based on the historical data. We specify a joint 
noninformative uniform initial prior for , i.e., .
Figure 2 shows the plots of DIC and LPML versus a0 for various values of J. We see from 
Figure 2 that DIC (LPML) is roughly a convex (concave) function of a0 for a given value of 
J and the entire DIC (LPML) curve for J = 5 is below (above) those corresponding to J = 2, 
J = 10, and J = 15. These results show that J = 5 is the best choice according to both the DIC 
and LPML criteria. In terms of a0, the respective best DIC values for J = 2, 5, 10, and 15 are 
1040.626, 1038.072, 1044.742, and 1045.578, attained at a0 = 0.2, 0.5, 0.6, and 0.7 while the 
respective best LPML values for J = 2, 5, 10, and 15 are −520.324, −519.06, −522.403, and 
−522.902, attained at a0 = 0.3, 0.5, 0.6, and 0.7. These results empirically show that when 
the model becomes more complex (i.e., J becomes larger), the optimal a0 becomes larger. 
This is quite interesting as these results essentially imply that the historical and current data 
become more comparable under more complex models.
The posterior estimates of the regression parameters, including posterior means, posterior 
standard deviations (SDs), and 95% HPD intervals, for a0 = 0, 0.5, and 1 under J = 5 are 
given in Table 2. From Table 2, we see that (i) the posterior SDs decrease as a0 increases for 
all parameters, implying that the incorporation of historical data improves the precision of 
the posterior estimates; (ii) the 95% HPD intervals for β2, β3, β4, and β1 + β4 include 0 for all 
a0's; and (iii) the 95% HPD intervals for β0 and β1 include 0 when a0 = 0 but do not include 
0 when a0 = 0.5 and 1. Note that based on our notation and model setup, β1 quabtufues the 
treatment effect for female patients while β1 + β4 captures the treatment effect for male 
patients. We also see from Table 2 that the posterior means and 95% HPD intervals are 
−0.311 and (−0.620, 0.012), −0.340 and (−0.616, −0.078), and −0.352 and (−0.593, −0.126) 
for a0 = 0, 0.5, and 1, respectively, for β1; and −0.022 and (−0.447, 0.416), −0.108 and 
(−0.461, 0.259), and −0.147 and (−0.442, 0.180) for a0 = 0, 0.5, and 1, respectively, for β1 + 
β4. We also computed the posterior estimates of the hazard ratios (HRs) of the treatment 
effect for females (exp(β1)) and for males (exp(β1 + β4)). The estimated HRs of the 
treatment effect and corresponding 95% HPD intervals are 0.732 and (0.538, 1.012), 0.712 
and (0.540, 0.925), and 0.703 and (0.553, 0.882) for a0 = 0, 0.5, and 1, respectively, for 
females; and 0.978 and (0.640, 1.516), 0.898 and (0.631, 1.295), and 0.864 and (0.643, 
1.197) for a0 = 0, 0.5, and 1, respectively, for males. The above results indicate that the 
treatment effect favoring IFN with respect to RFS can be seen only for female patients but 
not for male patients.
8. The Power Prior in Bayesian Design
Many examples of the use of the power prior in experimental design settings can be found in 
Spiegelhalter, Abrams, and Myles (2004). The power prior has also been used more recently 
in clinical trial design settings in [21, 24, 38, 39]. Specifically, Chen et al. [21] developed a 
new and general method to determine Bayesian sample size using historical data for a non-
inferiority trial. Ibrahim et al. [24] and Chen et al. [38, 39] adapted this method using the 
partial borrowing power prior in Bayesian meta-experimental design as well as Bayesian 
design for superiority trials with recurrent events data.
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To put the methodology in a specific context, Chen et al. [21] considered designing a 
clinical trial to evaluate the performance of a new generation of drug-eluting stents (DES) 
(“test device”) with a non-inferiority comparison to the first generation of DES (“control 
device”). The trial had two arms: test device and control device. The primary endpoint is the 
12-month Target Lesion Failure (TLF) (binary) composite endpoint, which is an ischemia-
driven revascularization of the target lesion (TLR), myocardial infarction (MI) (Q-wave and 
non-Q-wave) related to the target vessel, or (cardiac) death related to the target vessel. 
Historical data were available from two previous trials on the first generation of DES. The 
first trial conducted in 2002 evaluated the safety and effectiveness of the slow release 
paclitaxel-eluting stent for treatment of de novo coronary artery lesions. The second trial 
conducted in 2004 expanded on the first trial, studied more complex de novo lesions, and 
involved multiple overlapping stents and smaller and larger diameter stents. The historical 
data based on lesion size matched criteria are subsets of the data published in Stone et al. 
[66, 67]. The numbers of failures, the numbers of patients, and the percentages of the 12-
Month TLF were 44, 535, and 8.2% for historical trial 1 and 33, 304, and 10.9% for 
historical trial 2.
Let (yt, nt) and (yc, nc) be the data corresponding to the test device and the control device, 
respectively. Assume that the ratio of the two sample sizes, , is fixed and typically 
small. Thus,  and  where n = nt + nc is the total sample size, The goal of the 
trial is to show that the test device is non-inferior to the control device. We assume that yt 
and yc independently follow binomial distributions b(pt, nt) and b(pc, nc), respectively. Then, 
the joint distribution of y(n) = (yt, yc)′ is given by 
, where θ = (pt,pc). The design parameter is 
the difference between pt and pc, namely, pt – pc. The hypotheses for non-inferiority testing 
are H0: pt – Pc ≥ δ versus H1: pt – Pc <, where δ is a prespecified non-inferiority margin. The 
trial is successful if H1 is accepted. Let  and 
. Following Chen et al. [21], the key design quantity is 
defined as
(8.1)
where the indicator function 1{A} is 1 if A is true and 0 otherwise, γ > 0 is a prespecified 
Bayesian credible level, the probability  is computed with respect 
to the posterior distribution of θ given the data y(n) and the feting prior π(f)(θ), and the 
expectation Es is taken with respect to the marginal distribution of y(n) under the sampling 
prior π(s)(θ). Let  and  denote the closures of  and . Let  denote a sampling 
prior with support . Also let  denote a sampling prior with support 
. Then,  and  given in (8.1) corresponding to  and  are the 
Bayesian type I error and power, respectively.
Let yc0 = (yc01, yc02)′ = (44,33)′ denote the historical data for the control medical device. 
The partial borrowing power prior with fixed a0 = (a01, a02)′ is given by
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where , and π0(pt) and π0(pc) are initial priors. Assuming 
, the posterior distribution of pc is given by
(8.3)
and the normalized power prior for (pt, pc, a0) given multiple historical datasets yc0 is of the 
form
(8.4)
where  denotes 
the complete beta function, and b01 > 0 and b02 > 0 are prespecified hyperparameters. Note 
that in (8.4), we assume that the a0k's are independent and distributed as a0k ~ beta(b01, b02) 
for k = 1,2.
We consider (8.2) or (8.4) after integrating out a0 as the fitting prior . For the 
sampling prior, , l = 0,1, we take
(8.5)
where  is the design value of the 12 month TLF for the future data and Δ{A} denotes 
the point mass at the event A, that is, P(A) = 1.
As discussed in [21], we set the margin to be δ = 4.1%, took an improper beta(0,0) initial 
prior for π0(pc), and specified b01 = b02 = 1 for the initial priors of the a0k's in (8.4). In the 
sampling prior, we assumed a point mass prior at  for π(s)(pc), where 9.2% was the 
pooled proportion for the two historical control datasets. We first computed the powers and 
the type I errors for various sample sizes based on the Bayesian procedure without the 
incorporation of historical data (a0 = 0) as well as with power priors for random and fixed 
a0. Table 3 shows the results. From Table 3, we see that (i) without incorporation of 
historical data, a total sample size of 1480 is required in order to achieve 80% power; (ii) 
With incorporation of the historical data, a sample size of (nt, nc) = (810, 270) achieves 80% 
power; and (iii) the power prior with random a0 borrows approximately 30% of the 
historical data. Thus, the Bayesian sample size determination (SSD) procedure with 
incorporation of historical data leads to a reduction in the sample size.
To carry out a sensitivity analysis of the Bayesian SSD, we consider n = 1200 with nt = 900 
and nc = 300, three different values of , namely 8.0%, 9.2%, and 10.0%, and various 
Bayesian credible levels for γ. The powers and type I errors for the normalized power priors 
with various initial priors for a0k's as well as the power prior with fixed a0 = (0.3, 0.3)′ are 
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shown in Table 4. From this table, we see that the type I errors were not controlled at 5% for 
both the normalized power prior and the power prior with fixed a0 = (0.3, 0.3)′ when γ = 
0.95% and , because of the fact that the historical data and the current data from the 
control device are not compatible. Also, we see that the type I errors corresponding to the 
normalized power prior is quite sensitive to the specification of the initial prior beta(b01, 
b02) for a0k in (8.4). However, when γ increases or when the historical control data are 
downweighted, the type I error decreases. In particular, when γ = 0.96 and 0.97, the type I 
errors were 0.049 and 0.035 for the power prior with fixed a0 = (0.3, 0.3)′. In addition, if a 
point mass sampling prior at pc = 8.0% is assumed, the type I errors under the normalized 
power prior were 0.041 when (b01, b02) = (1,1) and γ = 0.97 and 0.047 when (b01, b02) = 
(1,10) and γ = 0.96.
In the binomial setting, closed-form expressions for the penalized likelihood-type criterion 
(PLC), the marginal likelihood criterion (MLC), and the deviance information criterion 
(DIC) in Section 5 are available. Let 
. Using (8.3), assuming an improper beta(0,0) initial prior for pc, and ignoring the binomial 
coefficient , we have
(8.6)
The guide values of a0 based on PLC and MLC are given as
(8.7)
,  and  and 
C(a0) are defined in (8.6) and (8.4), respectively. Ignoring , we take the deviance 
function as . Using (8.3), the posterior 
mean of pc is 
. It 
can be shown that the posterior mean of Dev(pc) is given by
(8.8)
where  is the digamma function. Then, the guide value of a0 based on 
DIC is given by
(8.9)
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where  is given by (8.8). The powers and type I errors under these 
three guide values are also given in Table 4. From this table, we see that (i) the power prior 
with  leads to a slightly lower power but a better controlled type I error; (ii) the 
powers and type I errors under the power priors with  and  are similar; and (iii) 
both  and  require higher Bayesian credible levels in order to control the type I 
errors and maintain good powers at the same time.
9. Concluding Remarks
We have provided a comprehensive review of the power prior and its applications in this 
article. As seen in earlier sections, the power prior has been used in a wider variety of 
contexts and disciplines, ranging from experimental design to data analysis. We also 
demonstrated a large number of attractive theoretical properties of the power for inference, 
such as its asymptotic normality, conjugacy, log-concavity for Gibbs sampling, its 
connection to hierarchical models, its semi-automatic nature for variable subset selection, 
and its important role in the design of clinical trials. The power prior continues to be highly 
used today, especially in clinical trials contexts, in both design and analysis settings. It is 
becoming a standard approach to informative prior elicitation. It is also one of the 
recommended priors by the US Food and Drug Administration (FDA) for analyzing and 
designing medical device trials.
The power prior has also been implemented in software packages such as SAS Proc MCMC 
and WinBUGS. Some comments are in order here for the different variations of the power 
prior. First, we note that the normalized power prior (2.4) is computationally difficult to 
work with especially in regression settings, and thus the joint power prior (2.3) is more 
preferred for this purpose. Second, the partial borrowing power prior is flexible and different 
than (2.3) in that it allows borrowing information from historical data on a subset of the 
model parameters that is common to both the historical dataset and the current study. The 
partial borrowing power prior is most useful in clinical trials setting, for example, where one 
only has historical data on the control arm, and no historical data on the treatment arm for 
the current study. Third, the partial discounting power prior, which is different than the 
partial borrowing power prior, is most useful in settings with latent variables or random 
effects, where one wishes to discount the likelihood function of the historical data but not 
discount the distribution of the latent variables or the random effects. Fourth, the order 
restricted power prior, which is another variation of the power prior, is quite attractive in 
combining historical data from different types of previous trials with ordered importance. 
The partial borrowing power prior, the partial discounting power prior, and the order 
restricted power prior all show great promise for future use in both the design and analysis 
of clinical trials. All of these three variations of the power prior are promising topics of 
future research.
Regarding fixed or random a0 in design or analysis, our experience shows that taking a0 
fixed and doing several sensitivity analyses for different values of a0 is much 
computationally feasible and easier to interpret than taking a0 random. In addition, a fixed 
a0 may also be more convenient to elicit via expert opinion. The a0 random case is 
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computationally very difficult and it often gives answers similar to the a0 fixed case, so its 
advantages appear to be minimal. As a result, using fixed a0 may be more preferred and 
desirable in many applications. A related issue is the specification of a useful guide value for 
a0. In Section 5, we have derived the closed-form expressions of the penalized likelihood-
type criterion, marginal likelihood criterion, DIC, and LPML criterion for the linear model 
with known sampling-level variances. When the sampling-level variances are unknown, the 
closed-form expressions of these criteria except for the LPML criterion can still be derived. 
Thus, for the LPML criterion, a sampling-based Monte Carlo method needs to be used in 
order to obtain a guide value of a0. Although the approaches based on the penalized 
likelihood-type, marginal likelihood, DIC, and LPML criteria are attractive, their properties 
have not been fully investigated and much more work needs to be done in finding optimal 
guide values for a0. This is also a topic of future research.
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Plots of coverage probability (left panel) and rMSE (right panel) of βi, where ○ indicates the 
results based on fixed values of a0 (evenly-spaced from 0 to 1), and ◆, ▲, ■, ●, and Δ 
display the results based on , and , and the normalized power 
prior.
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DIC and LPML plots for E1684 and E1690.
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Table 1
Simulation Results for the Posterior Estimates of β1
a 0 Scenario I Scenario II
Estimate SD CP rMSE Estimate SD CP rMSE
0.00 1.9989 0.0521 0.9492 0.0523 1.9989 0.0521 0.9492 0.0523
0.10 1.9989 0.0510 0.9538 0.0503 1.9887 0.0510 0.9476 0.0515
0.20 1.9990 0.0499 0.9580 0.0486 1.9793 0.0499 0.9359 0.0528
0.30 1.9990 0.0489 0.9588 0.0473 1.9707 0.0489 0.9137 0.0556
0.40 1.9990 0.0480 0.9604 0.0462 1.9627 0.0480 0.8887 0.0594
0.50 1.9990 0.0472 0.9606 0.0454 1.9552 0.0472 0.8540 0.0637
0.60 1.9991 0.0463 0.9597 0.0448 1.9483 0.0463 0.8103 0.0683
0.70 1.9991 0.0456 0.9566 0.0443 1.9419 0.0456 0.7615 0.0731
0.80 1.9991 0.0448 0.9554 0.0440 1.9358 0.0448 0.7089 0.0778
0.90 1.9991 0.0441 0.9523 0.0439 1.9302 0.0441 0.6492 0.0824
1.00 1.9991 0.0435 0.9487 0.0438 1.9249 0.0435 0.5906 0.0870
a0,PLC
opt 1.9989 0.0510 0.9535 0.0503 1.9891 0.0510 0.9476 0.0515
a0,MLC
opt 1.9992 0.0448 0.9471 0.0459 1.9794 0.0492 0.8935 0.0583
a0,DIC
opt 1.9992 0.0448 0.9474 0.0458 1.9783 0.0491 0.8913 0.0587
a0,LPML
opt 1.9992 0.0448 0.9471 0.0458 1.9784 0.0491 0.8915 0.0587
Random 1.9991 0.0472 0.9579 0.0455 1.9687 0.0512 0.9003 0.0601
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Table 2
Posterior Estimates for E1690 using E1684 as the historical data (J=5)
a 0 Parameter Posterior Mean Posterior SD 95% HPD Interval
0.0 β 0 0.204 0.127 (−0.043, 0.451)
β 1 −0.311 0.163 (−0.620, 0.012)
β 2 0.119 0.067 (−0.008, 0.252)
β 3 −0.290 0.195 (−0.675, 0.091)
β 4 0.290 0.274 (−0.263, 0.805)
β1 + β4 −0.022 0.223 (−0.447, 0.416)
0.5 β 0 0.260 0.101 (0.056, 0.450)
β 1 −0.340 0.138 (−0.616, −0.078)
β 2 0.094 0.055 (−0.010, 0.204)
β 3 −0.219 0.161 (−0.536, 0.091)
β 4 0.233 0.230 (−0.209, 0.682)
β1 + β4 −0.108 0.183 (−0.461, 0.259)
1.0 β 0 0.286 0.088 (0.110, 0.454)
β 1 −0.352 0.120 (−0.593, −0.126)
β 2 0.086 0.048 (−0.013, 0.175)
β 3 −0.182 0.137 (−0.461, 0.078)
β 4 0.205 0.197 (−0.179, 0.599)
β1 + β4 −0.147 0.159 (−0.442, 0.180)
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Table 3
Powers and Type I Errors for 12-Month TLF with 
Total Sample Size 1000 1080 1200 1280 1480
nt 750 810 900 960 1110
nc 250 270 300 320 370
No Borrowing a0 = (0, 0) Power 0.648 0.676 0.718 0.738 0.800
Type I Error 0.049 0.048 0.048 0.050 0.044
Random a0 using (8.4) Power 0.843 0.878 0.897 0.902 0.914
Type I Error 0.038 0.031 0.029 0.036 0.039
Fixed a0 = (0.3, 0.3) Power 0.840 0.856 0.884 0.892 0.923
Type I Error 0.030 0.027 0.028 0.030 0.032
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Table 4
Powers and Type I Errors under Three 's and Various γ's for 12-Month TLF with (nt, nc) = (900, 300)
Fitting Prior γ pc
∗ = 8.0 % pc
∗ = 9.2 % pc
∗ = 10.0 %
Power Type I Error Power Type I Error Power Type I Error
Power Prior with a0k ~ beta(b01, b02) in (8.4)
(b01, b02) = (1, 1) 0.95 0.945 0.070 0.882 0.039 0.799 0.034
(b01, b02) = (1, 5) 0.95 0.916 0.061 0.832 0.033 0.760 0.026
(b01, b02) = (1, 10) 0.95 0.868 0.053 0.791 0.038 0.728 0.032
(b01, b02) = (1, 1) 0.96 0.935 0.055 0.880 0.022 0.765 0.026
0.97 0.917 0.041 0.848 0.015 0.719 0.009
(b01, b02) = (1, 5) 0.96 0.899 0.047 0.803 0.027 0.722 0.021
Power Prior with fixed a0 = (a01, a02)′
a0 = (0.3, 0.3) 0.95 0.965 0.065 0.884 0.028 0.788 0.018
0.96 0.953 0.049 0.856 0.021 0.750 0.013




0.95 0.918 0.055 0.829 0.035 0.755 0.027
0.96 0.898 0.045 0.798 0.026 0.722 0.021




0.97 0.900 0.072 0.851 0.046 0.780 0.028




0.97 0.912 0.071 0.854 0.041 0.788 0.027
0.98 0.889 0.051 0.815 0.028 0.738 0.018
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